Future of Healthcare

SpineGuard Announces a New Partnership with Sorbonne, CNRS and Inserm to associate its DSG® Technology With Ultrasound and Serve Surgical Robots

SpineGuard | June 08, 2022

SpineGuard Announces

pineGuard an innovative company that deploys its DSG sensing technology to secure and streamline the placement of bone implants, announces the launch of a new three-year collaboration program with two labs of Sorbonne University CNRS and Inserm: the ISIR.

DSG is based on the local measurement of electrical conductivity of tissues in real time without X-ray imaging, with a sensor located at the tip of the drilling instrument. Its efficacy was proven by more than 90,000 surgeries across the globe and 19 scientific publications. SpineGuard has entered in 2017 a collaboration with ISIR for the application of DSG to surgical robots and the enhancement of their safety, accuracy, and autonomy.

SpineGuard and ISIR capitalize on first order outcomes published so far…

At the close of a first collaboration phase, SpineGuard announced sub-millimetric accuracy experimental outcomes in bone boundary detection and automatic stop of a vertebral drilling performed by a robot using the DSG technology. These impressive outcomes were presented as they were produced successively at the Hamlyn medical robotics conference in London in May 2019, receiving the first price for best scientific paper, then in plenary session at the SMISS minimally invasive spine surgery (SMISS) in Las Vegas in November 2021, and lastly during the CRAS conference in Naples in April 2022.

… and join forces with the LIB laboratory in order to add ultrasound to the project.

Encouraged by this success, the research and development teams wish to go even further in surgical robots advancement: the guidance technologies that allow the robot to position itself properly relative to the patient to find the drilling entry point rely today on X-Ray imaging, dangerous for health, in combination with space-consuming optical registration. SpineGuard has long explored the possibility to use ultrasound complementarily to DSG for this preliminary step, before the tool is penetrating bone, and was granted two families of international patents on that topic. The LIB laboratory, who features an international level expertise in the field of ultrasound imaging, answered with enthusiasm the invitation to join the project. SpineGuard, ISIR and LIB thus start a new 3-year collaboration that is expected to produce breakthrough results in the field.

We are happy to launch this partnership that will allow us to go even further in improving surgical robots in orthopedics. This new phase of the project aims at enabling robots to perform bone drilling and cutting, as well as implant placement, in a secured and more autonomous manner in the human skeleton. Our goal is to implement first-class collaboration between French Research and Industry and trigger commercial ventures in the orthopedic field via strategic agreements with industry partners.”

Stéphane Bette, co-founder and Deputy CEO of SpineGuard

Guillaume Morel, Professor at Sorbonne University and ISIR Director, and Brahim Tamadazte, Researcher at CNRS and member of ISIR, added: “We are delighted to continue the close and dynamic collaboration initiated in 2017 with SpineGuard. The entry of robotics and associated new technologies in operating room is no doubt one of the biggest medical advances of the last twenty years. Robotic approaches often allow the surgical gesture to be less invasive, more accurate, safe and intuitive in numerous surgical procedures. The first outcomes from the previous collaboration gave us more visibility on the clinical added value that a robot with original and effective sensors can bring to Orthopedic Surgery in general and Spine in particular. This new collaboration will be about ultrasonic sensors coupled with robotics. This original and promising association will allow the surgeon to define the entry point and the pedicle screw trajectory accurately and non-invasively, without relying on ionizing or costly preoperative imaging (scanner, MRI). The association of two prestigious labs of Sorbonne University (ISIR and LIB), whose competencies are highly complementary to SpineGuard’s industrial vision constitute a stimulating work environment favorable to innovation. The journey with SpineGuard goes on for three more years with a target of several technologic and scientific innovations to serve patients and care providers.”

Quentin Grimal, Professor at Sorbonne University and Manager of the team “Ultrasound and imaging for bone quality characterization” at LIB, concludes: “Using ultrasound to position a surgical tool is particularly relevant. Ultrasounds are danger free and provide real time information about interfaces, bone anatomy, even bone mechanical quality. The use of an ultrasound probe should allow to position the robotic arm in an optimal manner to place pedicle screws. In general, echography does not allow to see beyond the bone surfaces because ultrasounds are strongly reflected at the surface and strongly attenuated when propagating in bone. Low amplitude signals coming from inside bone can however be exploited through specific treatments which are a specialty of our team. Our team, pioneer in ultrasound utilization to probe bone, has introduced several approaches that offer an alternative to X-Rays for characterization of trabecular or cortical bone health. For our team, this partnership with SpineGuard and ISIR is a great fit: it will accelerate methodology and instrument developments for a broader utilization of ultrasound in orthopedic surgery. We are very happy to participate in this innovation rich project.”

About SpineGuard®

Founded in 2009 in France and the USA by Pierre Jérôme and Stéphane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 90,000 surgical procedures worldwide. Nineteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these strong fundamentals and several strategic partnerships, SpineGuard has expanded the scope of its DSG® technology in innovative applications such as the « smart » pedicle screw, the DSG Connect visualization and registration interface, dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer. SpineGuard has engaged in multiple ESG initiatives.

About ISIR

ISIR is one of the largest French Research institutions in robotics and intelligent systems, reporting mainly to Sorbonne University, CNRS (National Center for Scientific Research) and Inserm (National institute for health and medical research). It regroups more than 50 teaching researchers and permanent researchers and approximately 80 PhD ad post-doc students. ISIR is structured around 6 research teams focused on artificial intelligence and machine learning, mobile robotics, small scale robotics, assistance robotics (physical therapy and mobility support), human-robot interaction and surgical gesture assistance. ISIR has a rich expertise in the design of innovative robotic architectures, simulation and control, clinical validation and transfer of high industrial potential results. Over the last 5 past years, 10 pre-clinical or clinical studies were conducted at ISIR. 8 patents were granted, and 2 start-up companies created.

About LIB

The Laboratory for biomedical imaging (LIB) is specialized in Fundamental and Applied Research for biomedical morphologic imaging methods, functional and molecular on small animal and human. It reports to Sorbonne University, CNRS and INSERM. It regroups 35 permanent researchers and teaching researchers, of whom half are also hospital practitioners, approximately 10 engineers and technicians and more than 30 PhD students and post-docs. LIB is structured around 6 teams whose focuses correspond to key priorities of 21st century Public Health: cancer, cardiovascular and neurologic diseases, bone quality. LIB develops new diagnostic and treatments methods exploiting various modalities: ultrasound, MRI, CT, SPECT-PET, etc. LIB has a strong commitment to technology transfer. Over the last 5 years, 6 patents were granted, 7 software were filed, and 5 startup companies launched.

Spotlight

The University of Galway is bringing 5G connectivity to Clare Island in Ireland, improving digital inclusion and access to quality care.

Spotlight

The University of Galway is bringing 5G connectivity to Clare Island in Ireland, improving digital inclusion and access to quality care.

Related News

Health Technology, Healthcare Analytics

UnisLink Extends its Revenue Cycle Management Leadership with the Acquisition of AQREVA and Doctors' Resource Specialists

PRNewswire | August 22, 2023

UnisLink, a global leader in revenue cycle and population health management services for independent physician practices, announced the acquisition of AQREVA and Doctors' Resource Specialists ("DRS"). This strategic acquisition, the second for UnisLink in the last two months, strengthens UnisLink's position as a comprehensive provider of revenue cycle solutions and expands the company's geographic reach. The addition of AQREVA and DRS aligns with UnisLink's growth strategy, enabling the company to enter new geographies and enhance its services to physician practices and other healthcare providers. With an unwavering commitment to innovation and client satisfaction, UnisLink is dedicated to delivering tailored revenue cycle management solutions that improve the financial performance of its customers. "We are excited to welcome AQREVA and DRS to the UnisLink family," said David Strand, Executive Chairman of UnisLink. "This strategic acquisition reinforces UnisLink's commitment to improving the financial health of physician groups through advanced technologies and unmatched service levels. Together, we will offer a growing range of services and solutions to our clients, enabling them to focus on patient care, not financial and administrative burdens." The addition of AQREVA and DRS, both founded over 25 years ago with offices in Arizona, North Dakota, South Dakota, Oklahoma and Montana, expands the collective organization's capacity to deliver revenue cycle management and population health services to a variety of healthcare providers across the heartland. UnisLink's proprietary revenue intelligence technologies will make a significant impact on both the quality of the services and reporting offered to both AQREVA and DRS customers. "We are excited about the impact UnisLink's technology will have on our offering," noted AQREVA President, Paula Tollerud. "And we are extremely pleased with the alignment of the organizational culture and values of our two organizations. We know we are adding value to the overall UnisLink organization and feel appreciated and valued for what we bring to the table." Sue Magalnick and Julie Serbin who lead the DRS business added "DRS and UnisLink have been respected competitors, particularly in the Phoenix region, for quite some time. We are thrilled to be coming together as one organization and excited about the impact UnisLink's technology and breadth of resources will bring to our customer base." The integration of AQREVA and DRS is being executed with thoughtful planning and coordination to ensure an enhanced service level for clients and partners. The combined companies will operate under the UnisLink brand. The AQREVA and DRS leadership will continue in their roles as part of the expanded UnisLink organization. The existing operations of AQREVA and DRS will add to UnisLink's seven regional Centers of Excellence, complementing the company's current operations in Phoenix AZ, Chicago IL, Latham NY, Valparaiso IN, Cleveland OH, New Brighton, Pennsylvania, and Hyderabad, India. The company is supported by its product development team located in Chennai, India. UnisLink is a portfolio company of Boston-based Riverside Partners. ABOUT UNISLINK UnisLink leverages its proprietary software solutions to provide end-to-end revenue cycle management and population health management services to independent physician groups, ACOs, and value-based care groups across the United States. Headquartered in Phoenix, AZ, the Company deploys unique technology, analytics, and skilled teams to enhance clinical outcomes while improving the financial performance of its customers.

Read More

Digital Healthcare, Healthcare Analytics

Syntellis Performance Solutions Launches Axiom™ Referral Patterns: A New Data Insights Solution to Drive Strategic Growth for Healthcare Organizations

Businesswire | July 05, 2023

Syntellis Performance Solutions, the leading provider of enterprise performance management software, data and intelligence solutions, today announced the availability of Referral Patterns ― a robust module developed to identify referral leakage in a healthcare network. It is a powerful addition to the Axiom™ Market Opportunity Visualization solution designed to deliver executive-level insights and data intelligence to help healthcare leaders determine where, when, and how to grow through easy-to-use visualizations. The Referral Patterns module leverages Syntellis’ proprietary All-Payer Claims Dataset which is critical to identify referral leakage in a hospital’s service area. The module is purposefully designed to align growth and retention strategies with a hospital or health system’s physicians. This makes it easier to map referrals to and from physicians within a service area for improved understanding of physician-specific referral patterns, patient interactions, facility loyalties and health system relationships. “Healthcare leaders need intuitive solutions that provide them the information needed for strategic growth planning, but they are often faced with scarce and complex market data,” said Flint Brenton, CEO of Syntellis Performance Solutions. “Our latest Referral Patterns module ― as part of the Axiom Market Opportunity Visualization solution ― solves this. It is a turning point in our industry as it allows users to quickly transform data into actionable intelligence and insights.” This new module also delivers a streamlined process to view patient cases performed and revenue generated by individual physicians and facilities, even providing breakdowns by care setting, provider specialty, facility, practice affiliation and zip code. In addition to Referral Patterns, other interactive modules within the Axiom Market Visualization solution include: Patient Origin & Out-Migration: an interactive claims visualization dashboard providing insights into where patients seek care, so healthcare finance leaders can identify growth opportunities and address out-migration Market Share & Trending: which uses State-specific data to deliver critical intelligence on a market and patients’ behaviors, so users can identify trends and changes in market demographics, calculate one’s share in the market, and see trends in patient origin, payer mix, and service lines utilized Future modules that will further help hospitals and health systems reduce costs and retain patients in their facilities include: Share of Care: providing a way to visualize the patient care journey across the care continuum including details on all the facilities and physicians that the patient has seen both inside and outside of the organization Profiles: equipping users with the ability to drill down into the data in a service area to develop an individual profile on a specific provider, facility, or procedure code to obtain more granular insights on physician and patient behavior About Syntellis Syntellis Performance Solutions provides innovative enterprise performance management software, data, and intelligence solutions for healthcare organizations. Its solutions include enterprise planning, cost and decision support, and financial and clinical analytics tools to elevate organizational performance and transform vision into reality. More than 2,800 organizations and 450,000 users rely on Axiom, Connected Analytics, and Stratasan software. With an HFMA Peer Review designation for a decade and No. 1 rankings from Black Book Research multiple years running, Syntellis helps healthcare providers acquire insights, accelerate decisions, and advance their business plans. For more information, please visit www.syntellis.com.

Read More

Health Technology

TeleVox Secures Odeza's Patient Engagement Unit from Ensemble Health

TeleVox | September 11, 2023

TeleVox and Ensemble will provide Ensemble's clients with an all-encompassing healthcare solution, from patient acquisition to post-discharge care. This announcement is yet another significant milestone in TeleVox's continuous rapid growth and expansion journey. This acquisition underscores TeleVox's commitment to strengthening its presence in the healthcare sector as it integrates Odeza's patient engagement business. TeleVox, a distinguished provider of state-of-the-art omnichannel digital patient engagement technology, has completed a significant acquisition by owning the Odeza patient engagement business from Ensemble Health Partners (Ensemble). Ensemble, recognized as a preeminent force in revenue cycle management, specializes in delivering its services to various healthcare institutions, including hospitals, health systems, and physician practices. TeleVox and Ensemble are committed to extending the reach and accessibility of TeleVox's cutting-edge technology to Ensemble's existing customer base. This strategic endeavor aims to deliver healthcare providers an all-encompassing solution that seamlessly caters to a broad spectrum of healthcare requirements, commencing with the initial patient acquisition phase and extending throughout the entirety of the patient journey. This comprehensive approach encompasses not only the discharge process but extends into subsequent phases of aftercare and beyond, equipping healthcare institutions with the essential tools and resources to optimize patient engagement, streamline operational workflows, and elevate the overall quality of care delivery. Additionally, this move positions TeleVox to enhance its capabilities further in providing innovative solutions, enabling healthcare providers to engage with patients in a more comprehensive and technologically advanced manner, ultimately advancing the healthcare industry. Vik Krishnan, President of TeleVox, expressed his welcome to Odeza joining the TeleVox family and highlighted that the acquisition of Odeza's patient engagement business aligns with TeleVox's longstanding commitment to tailored communication solutions for enhancing the patient experience, solidifying TeleVox's position as an industry leader. He also emphasized that making their patient engagement solutions accessible to Ensemble's extensive customer base will enable more healthcare providers to deliver exceptional patient care. Judson Ivy, Founder, President and CEO of Ensemble Health Partners, remarked, "This partnership strengthens each of our positions in the healthcare industry and delivers unmatched value to our customers." Meanwhile, the company unveiled Iris, an AI-powered omnichannel conversational virtual assistant tailored for healthcare providers, in April. The introduction of an automated reputation management solution in the month that followed this significant development gave hospitals, health systems, and physician practices the ability to manage and improve their online presence effectively.

Read More